section name header

Y-Site Injection Compatibility (1:1 Mixture)

Clindamycin phosphate

(Mfr: HOS)(Conc: 12 mg/mLa)

I

Oritavancin diphosphate

(Mfr: TAR)(Conc: 0.8, 1.2, and 2 mg/mLa)

Remarks:

Haze forms immediately with precipitate after 30 to 60 min

Ref:

2928